Neurotech International
- Short interest
- 0.01%
- +0.01 pp 30d
- as of 23 Jan 2026
- Reported shorts
- 143.2K
- Shares on issue
- 1.296B
Neurotech International (NTI) Short Interest
Neurotech International (ASX:NTI) had 0.01% of shares reported as short positions as of 23 Jan 2026, representing 143,231 shares. Neurotech International operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Neurotech International
Neurotech International focuses on developing wearable neurotechnology devices aimed at assisting individuals with neurological conditions, particularly autism. The company is positioned within the Health Care Equipment & Services industry on the ASX, seeking to provide innovative solutions for unmet needs in neurological care.
Company profile →Neurotech International (ASX:NTI) has 0.01% of its shares on issue reported as short positions as of 23 Jan 2026, or about 143,231 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.11% in December 2020. NTI is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads NTI today
- Zanger BreakoutWatchScore 67rank 1 of 1942
- CAN SLIMWatchScore 25rank 423 of 1541
- Minervini Trend TemplateWatchScore 39rank 408 of 1716
- Crowded-Short BreakoutWatchScore 33rank 114 of 1500
- Quality compoundersWatchScore 25rank 561 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
NTI fundamentals
In the year to 30 Jun 2026, Neurotech International (ASX:NTI) recorded revenue of A$44.6K and a net loss after tax of A$6.5M. A year earlier it recorded revenue of A$238 and a net loss after tax of A$10.6M. Net margin −14,647.2% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest NTI news
All news- Health Check: Neurotech shares surge on upbeat research report
stockhead · 14 Oct 2026
- Are Neurotech's (ASX:NTI) Registration Plans Taking Hold? - Kalkine Media
googlenews · 7 Oct 2026
- Change of Director's Interest Notice
asx · 6 Oct 2026
Company details
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss NTI
Start a research thread or post the first pulse update